Skip to content

Advertisement

  • Erratum
  • Open Access

Erratum to: Long-acting methylphenidate formulations in the treatment of attention-deficit/hyperactivity disorder: a systematic review of head-to-head studies

  • David Coghill1Email author,
  • Tobias Banaschewski2,
  • Alessandro Zuddas3,
  • Antonio Pelaz4,
  • Antonella Gagliano5 and
  • Manfred Doepfner6
BMC Psychiatry201515:202

https://doi.org/10.1186/s12888-015-0581-z

Received: 5 August 2015

Accepted: 5 August 2015

Published: 25 August 2015

The original article was published in BMC Psychiatry 2013 13:237

Correction

After publication of this work [1], we noted that a figure reproduced from Lopez et al. [2], was revised in an erratum.

In Figure three (Fig. 1 here), the uppermost solid line represents placebo and the lower solid line (at 0.5 h), represents Ritalin LA® 20 mg capsule. In addition, labelling of the x-axis should read “0.5, 1, 2, 3, 4, 6, 8” hours.
Figure 1
Fig. 1

Notes

Declarations

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Division of Neuroscience, Medical Research Institute, Ninewells Hospital and Medical School, Dundee, UK
(2)
Department of Child and Adolescent Psychiatry, Central Institute of Mental Health, Medical Faculty of Mannheim, University of Heidelberg, Mannheim, Germany
(3)
Department of Biomedical Sciences, University of Cagliari, Cagliari, Italy
(4)
Department of Child and Adolescent Psychiatry, Hospital Clinico Universitario San Carlos, Madrid, Spain
(5)
Department of Pediatric Science, University of Messina, Policlinico Universitario G. Martino, Messina, Italy
(6)
Department of Child and Adolescent Psychiatry, University of Cologne, Cologne, Germany

References

  1. Coghill D, Banaschewski T, Zuddas A, Pelaz A, Gagliano A, Doepfner M. Long-acting methylphenidate formulations in the treatment of attention-deficit/hyperactivity disorder: a systematic review of head-to-head studies. BMC Psychiatry. 2013;13:237.View ArticlePubMedPubMed CentralGoogle Scholar
  2. Lopez F, Silva R, Pestreich L, Muniz R. Comparative efficacy of two once daily methylphenidate formulations (Ritalin LA and Concerta) and placebo in children with attention deficit hyperactivity disorder across the school day. Paediatr Drugs. 2003;5:545–55.View ArticlePubMedGoogle Scholar

Copyright

© Coghill et al. 2015

Advertisement